Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
about
Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke modelPeptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery.Pathophysiology and Neuroprotective Strategies in Hypoxic-Ischemic Brain Injury and Stroke.Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.The neuroprotective potential of arginine-rich peptides for the acute treatment of traumatic brain injury.Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.Structural behaviour and gene delivery in complexes formed between DNA and arginine-containing peptide amphiphiles.Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion iPerinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs)
P2860
Q36007755-86079F52-8CB4-4E3B-A48E-5F80892AD336Q39008879-A886662E-9FD8-4669-980D-8C5A711D61DEQ41821231-58B48A68-0A44-4B8F-BDF3-B6286B579822Q42262589-1ABF4B75-88E5-4E1D-B639-DAE6F078699CQ42351442-A00828F2-DA17-4544-81BC-12BD08EB251DQ47132992-CAFC9D00-51F6-4A7F-9D40-F9D581305426Q48212687-DF9F9B56-AE49-4078-932A-724F24FCE5BEQ48430070-371DF52A-80FF-4EB4-9236-B46736DE3E40Q48931282-EA8FB076-22B2-40EC-AB61-55E1C1571BE1Q50094040-D0FDC8A7-23D7-4B08-A9E8-BE946CC4A52AQ50218513-FEC9A023-C235-4AC6-8C6B-58CB938EDD98Q51743465-558806D2-BE44-4FF4-AA9F-60B45A21EF69Q53981883-9B93AA82-24A1-47F3-94F5-11FFA3EF4B2DQ57929840-8A987D46-3234-4BB0-8E3B-BF99AC04FF15
P2860
Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Neuroprotective peptides fused ...... peptide endocytic properties.
@en
type
label
Neuroprotective peptides fused ...... peptide endocytic properties.
@en
prefLabel
Neuroprotective peptides fused ...... peptide endocytic properties.
@en
P2093
P1476
Neuroprotective peptides fused ...... peptide endocytic properties.
@en
P2093
Bruno P Meloni
Diego Milani
Neville W Knuckey
Ryan L O'Hare Doig
Ryan S Anderton
T Norman Palmer
P356
10.1016/J.PHARMTHERA.2015.06.002
P577
2015-06-03T00:00:00Z